Prior literature confirmed that MUC5AC across the membrane protein, CD44, mediated the initiation and progression of CC, and provided resistance to chemotherapy in CRC through the β-catenin/p53/p21 signaling pathways (87). The gene discussed is CD44; the disease is colorectal carcinoma.